Treatment of Acne Vulgaris

Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit involving increased sebum production, follicular hyperkeratinization, colonization by Cutibacterium acnes, and inflammation. Management is tailored to severity and uses topical and systemic agents that target these mechanisms.

Analyzing Each Statement

• 1. Topical benzoyl peroxide: A first-line topical agent with potent antimicrobial (bactericidal against C. acnes, without inducing resistance) and mild comedolytic/keratolytic action. It is used in mild to moderate acne and in combination regimens. Correct.
• 2. Topical antibiotics like clindamycin: Topical clindamycin (usually combined with benzoyl peroxide or a retinoid to prevent resistance) reduces C. acnes load and inflammation, and is a standard component of therapy for mild to moderate inflammatory acne. Correct.
• 3. Oral isotretinoin: A systemic retinoid that reduces sebaceous gland size and sebum output, normalizes follicular keratinization, and has anti-inflammatory and indirect antibacterial effects. It is the treatment of choice for severe nodulocystic, scarring, or treatment-resistant acne. Correct.
• 4. Oral ivermectin: Ivermectin is an antiparasitic/antihelminthic agent used for scabies, strongyloidiasis, and onchocerciasis. It is not a standard or approved treatment for acne vulgaris. (Topical ivermectin does have an established role in rosacea, which is a different condition, but this does not extend to oral ivermectin use in acne.) Incorrect in this context.

Conclusion

Topical benzoyl peroxide, topical antibiotics (clindamycin), and oral isotretinoin are all established, evidence-based treatments for acne vulgaris, whereas oral ivermectin has no accepted role in its management.

Therefore, the correct combination is 1, 2 and 3, making option C the correct answer.